Direct oral anticoagulants (DOACs)

被引：9
|
作者：
Vazquez, Sara [1 ]
Rondina, Matthew T. [2 ,3 ,4 ]
机构：
[1] Univ Utah, Hlth Sci Ctr, Univ Healthcare Thrombosis Serv, Salt Lake City, UT USA
[2] Univ Utah, Dept Internal Med, Div Gen Internal Med, Salt Lake City, UT 84112 USA
[3] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA
[4] George E Wahlen Salt Lake City VAMC, Dept Internal Med, Salt Lake City, UT USA
来源：
VASCULAR MEDICINE | 2015年 / 20卷 / 06期
关键词：
anticoagulants; apixaban; dabigatran; edoxaban; rivaroxaban; thrombosis; DVT; pulmonary embolism; PATIENT;
D O I：
10.1177/1358863X15600256
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.
引用
收藏
页码：575 / 577
页数：3
相关论文
共 50 条
  • [41] State of the art: Direct oral anticoagulants and transfusion
    Martin, A. -C.
    Godier, A.
    Smadja, D. M.
    Mauge, L.
    Fischer, A. -M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2017, 24 (03) : 154 - 159
  • [42] Liver injury from direct oral anticoagulants
    Juneja, Deven
    Nasa, Prashant
    Jain, Ravi
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (06) : 841 - 849
  • [43] The use of direct oral anticoagulants in inherited thrombophilia
    Jessica W. Skelley
    C. Whitney White
    Angela R. Thomason
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 24 - 30
  • [44] Assessing Direct Oral Anticoagulants in the Clinical Laboratory
    Gosselin, Robert C.
    Cuker, Adam
    CLINICS IN LABORATORY MEDICINE, 2024, 44 (03) : 551 - 562
  • [45] Direct oral anticoagulants. Dental update
    Dinkova, Atanaska
    Daskalov, Hristo
    Drangov, Martin
    Dandarov, Yavor
    JOURNAL OF IMAB, 2022, 22 : 17 - 20
  • [46] Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (08): : 1114 - 1122
  • [47] The use of direct oral anticoagulants in inherited thrombophilia
    Skelley, Jessica W.
    White, C. Whitney
    Thomason, Angela R.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) : 24 - 30
  • [48] Clinical trials with new direct oral anticoagulants
    Harenberg, J.
    Weiss, C.
    Marx, S.
    Zolfaghari, S.
    PHLEBOLOGIE, 2013, 42 (03) : 139 - 148
  • [49] The newer direct oral anticoagulants: a practical guide
    Thachil, Jecko
    CLINICAL MEDICINE, 2014, 14 (02) : 165 - 175
  • [50] Direct oral anticoagulants (DOACs) - dabigatran, rivaroxaban, apixaban, edoxaban - addition - EML
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 339 - 355
12345